Hendrik Thys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Program aimed to deliver early-stage clinical supply of plasmid DNA for drug substance manufacturing Charles River Laboratories International, Inc. (NYSE: CRL) and Ziphius Vaccines, a biopharmaceutical

Todd spencerChris cardonKerstin dolphHendrik thysVigene biosciencesAmy cianciarusoManufacturing servicesCharles river laboratories international incRiver laboratories internationalZiphius vaccinesCharles riverHigh qualityCognate bioservicesCobra biologicsSenior vice presidentGlobal biologics